The FDA shouldn't open the way for biosimilars for drugs approved before March 23, 2010, when Congress authorized the creation of a pathway for their approval, the Washington Legal Foundation said. The foundation weighed in to support a petition from Abbott Laboratories on the subject.
Legal foundation backs petition against pre-2010 biosimilars
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||